{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:51:15Z","timestamp":1777481475549,"version":"3.51.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","award":["Department of Surgery Internal Grant"],"award-info":[{"award-number":["Department of Surgery Internal Grant"]}],"id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10120-026-01723-0","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:41:40Z","timestamp":1772880100000},"page":"635-649","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term quality of life, financial toxicity, and decision regret following therapeutic and prophylactic gastrectomy for cancer"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0140-3963","authenticated-orcid":false,"given":"Frank G.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1837-0291","authenticated-orcid":false,"given":"Jack W.","family":"Sample","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6242-5221","authenticated-orcid":false,"given":"Robert A.","family":"Vierkant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara K.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7370-3071","authenticated-orcid":false,"given":"Steven","family":"Bowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7979-6766","authenticated-orcid":false,"given":"Nabil","family":"Wasif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3776-527X","authenticated-orcid":false,"given":"Mark J.","family":"Truty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7960-3254","authenticated-orcid":false,"given":"Michael L.","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3654-8601","authenticated-orcid":false,"given":"Cornelius A.","family":"Thiels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7753-097X","authenticated-orcid":false,"given":"Travis E.","family":"Grotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"1723_CR1","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L et al. Global Cancer Observatory: Cancer Today - Stomach [Internet]. Lyon, France: International Agency for Research on Cancer; 2024 [cited 2026 January 15]. Available from: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/cancers\/7-stomach-fact-sheet.pdf"},{"issue":"1","key":"1723_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"},{"key":"1723_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejca.2017.10.032","volume":"88","author":"H Wang","year":"2018","unstructured":"Wang H, Li B, Liu Z, Gong J, Shao L, Ren J, et al. HER2 copy number of circulating tumour DNA functions as a biomarker to predict and monitor trastuzumab efficacy in advanced gastric cancer. Eur J Cancer. 2018;88:92\u2013100. https:\/\/doi.org\/10.1016\/j.ejca.2017.10.032.","journal-title":"Eur J Cancer"},{"issue":"12","key":"1723_CR4","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41591-020-1063-5","volume":"26","author":"Y Nakamura","year":"2020","unstructured":"Nakamura Y, Taniguchi H, Ikeda M, Bando H, Kato K, Morizane C, et al. Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies. Nat Med. 2020;26(12):1859\u201364. https:\/\/doi.org\/10.1038\/s41591-020-1063-5.","journal-title":"Nat Med"},{"issue":"19","key":"1723_CR5","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1200\/JCO.2011.36.7136","volume":"30","author":"SR Smalley","year":"2012","unstructured":"Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, et al. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol. 2012;30(19):2327\u201333. https:\/\/doi.org\/10.1200\/JCO.2011.36.7136.","journal-title":"J Clin Oncol"},{"issue":"25","key":"1723_CR6","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa2004413","volume":"382","author":"K Shitara","year":"2020","unstructured":"Shitara K, Bang YJ, Iwasa S, Sugimoto N, Ryu MH, Sakai D, et al. Trastuzumab deruxtecan in previously treated HER2-positive gastric cancer. N Engl J Med. 2020;382(25):2419\u201330. https:\/\/doi.org\/10.1056\/NEJMoa2004413.","journal-title":"N Engl J Med"},{"issue":"10","key":"1723_CR7","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/jamaoncol.2020.3370","volume":"6","author":"K Shitara","year":"2020","unstructured":"Shitara K, Van Cutsem E, Bang YJ, Fuchs C, Wyrwicz L, Lee KW, et al. Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer: the KEYNOTE-062 phase 3 randomized clinical trial. JAMA Oncol. 2020;6(10):1571\u201380. https:\/\/doi.org\/10.1001\/jamaoncol.2020.3370.","journal-title":"JAMA Oncol"},{"issue":"4","key":"1723_CR8","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s10120-021-01173-w","volume":"24","author":"N Boku","year":"2021","unstructured":"Boku N, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, et al. Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab. Gastric Cancer. 2021;24(4):946\u201358. https:\/\/doi.org\/10.1007\/s10120-021-01173-w.","journal-title":"Gastric Cancer"},{"issue":"10294","key":"1723_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CHECKMATE 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398(10294):27\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(21)00797-2.","journal-title":"Lancet"},{"issue":"11","key":"1723_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S1470-2045(23)00515-6","volume":"24","author":"SY Rha","year":"2023","unstructured":"Rha SY, Oh DY, Ya\u00f1ez P, Bai Y, Ryu MH, Lee J, et al. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol. 2023;24(11):1181\u201395. https:\/\/doi.org\/10.1016\/S1470-2045(23)00515-6.","journal-title":"Lancet Oncol"},{"issue":"10389","key":"1723_CR11","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","volume":"401","author":"K Shitara","year":"2023","unstructured":"Shitara K, Lordick F, Bang YJ, Enzinger P, Ilson D, Shah MA, et al. Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial. Lancet. 2023;401(10389):1655\u201368. https:\/\/doi.org\/10.1016\/S0140-6736(23)00620-7.","journal-title":"Lancet"},{"issue":"8","key":"1723_CR12","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1038\/s41591-023-02465-7","volume":"29","author":"MA Shah","year":"2023","unstructured":"Shah MA, Shitara K, Ajani JA, Bang YJ, Enzinger P, Ilson D, et al. Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial. Nat Med. 2023;29(8):2133\u201341. https:\/\/doi.org\/10.1038\/s41591-023-02465-7.","journal-title":"Nat Med"},{"issue":"11","key":"1723_CR13","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/bjs.9891","volume":"102","author":"WO de Steur","year":"2015","unstructured":"de Steur WO, Hartgrink HH, Dikken JL, Putter H, van de Velde CJ. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial. Br J Surg. 2015;102(11):1388\u201393. https:\/\/doi.org\/10.1002\/bjs.9891.","journal-title":"Br J Surg"},{"issue":"3","key":"1723_CR14","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1245\/s10434-024-16545-6","volume":"32","author":"A Dehal","year":"2025","unstructured":"Dehal A, Woo Y, Glazer ES, Davis JL, Strong VE, Society of Surgical Oncology Gastrointestinal Disease Site Workgroup. D2 lymphadenectomy for gastric cancer: advancements and technical considerations. Ann Surg Oncol. 2025;32(3):2129\u201340. https:\/\/doi.org\/10.1245\/s10434-024-16545-6.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"1723_CR15","doi-asserted-by":"publisher","first-page":"103663","DOI":"10.1016\/j.esmoop.2024.103663","volume":"9","author":"F Lordick","year":"2024","unstructured":"Lordick F, Van Cutsem E, Shitara K, Xu RH, Ajani JA, Shah MA, et al. Health-related quality of life in patients with CLDN18.2-positive, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma: results from the SPOTLIGHT and GLOW clinical trials. ESMO Open. 2024;9(8):103663. https:\/\/doi.org\/10.1016\/j.esmoop.2024.103663.","journal-title":"ESMO Open"},{"issue":"4","key":"1723_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/SLA.0000000000006503","volume":"281","author":"HJ Lee","year":"2025","unstructured":"Lee HJ, Kim YW, Park DJ, Han SU, Ryu KW, Kim HH, et al. Laparoscopic pylorus-preserving gastrectomy versus distal gastrectomy for early gastric cancer: a multicenter randomized controlled trial (KLASS-04). Ann Surg. 2025;281(4):573\u201381. https:\/\/doi.org\/10.1097\/SLA.0000000000006503.","journal-title":"Ann Surg"},{"issue":"2","key":"1723_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejso.2009.09.008","volume":"36","author":"K Avery","year":"2010","unstructured":"Avery K, Hughes R, McNair A, Alderson D, Barham P, Blazeby J. Health-related quality of life and survival in the 2 years after surgery for gastric cancer. Eur J Surg Oncol. 2010;36(2):148\u201354. https:\/\/doi.org\/10.1016\/j.ejso.2009.09.008.","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"1723_CR18","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/pon.1974","volume":"21","author":"LF O\u00f1ate-Oca\u00f1a","year":"2012","unstructured":"O\u00f1ate-Oca\u00f1a LF, Vel\u00e1zquez-Monroy N, V\u00e1zquez L, Espinosa-Mireles-de-Villafranca P, N\u00fa\u00f1ez-Rosas E, Ovando-Lezama M, et al. Clinical validation of the EORTC QLQ-OG25 questionnaire for the evaluation of health-related quality of life in Mexican patients with esophagogastric cancers. Psychooncology. 2012;21(7):745\u201353. https:\/\/doi.org\/10.1002\/pon.1974.","journal-title":"Psychooncology"},{"key":"1723_CR19","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1016\/S1743-9191(13)60028-X","volume":"11","author":"S Rausei","year":"2013","unstructured":"Rausei S, Mangano A, Galli F, Rovera F, Boni L, Dionigi G, et al. Quality of life after gastrectomy for cancer evaluated via the EORTC QLQ-C30 and QLQ-STO22 questionnaires: surgical considerations from the analysis of 103 patients. Int J Surg. 2013;11:S104\u20139. https:\/\/doi.org\/10.1016\/S1743-9191(13)60028-X.","journal-title":"Int J Surg"},{"issue":"1","key":"1723_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/SLA.0000000000000446","volume":"260","author":"E Worster","year":"2014","unstructured":"Worster E, Liu X, Richardson S, Hardwick RH, Dwerryhouse S, Caldas C, et al. The impact of prophylactic total gastrectomy on health-related quality of life: a prospective cohort study. Ann Surg. 2014;260(1):87\u201393. https:\/\/doi.org\/10.1097\/SLA.0000000000000446.","journal-title":"Ann Surg"},{"issue":"3","key":"1723_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ejso.2021.08.031","volume":"48","author":"N van der Wielen","year":"2022","unstructured":"van der Wielen N, Daams F, Rosati R, Parise P, Weitz J, Reissfelder C, et al. Health related quality of life following open versus minimally invasive total gastrectomy for cancer: results from a randomized clinical trial. Eur J Surg Oncol. 2022;48(3):553\u201360. https:\/\/doi.org\/10.1016\/j.ejso.2021.08.031.","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"1723_CR22","doi-asserted-by":"publisher","first-page":"znae286","DOI":"10.1093\/bjs\/znae286","volume":"111","author":"BE Byrne","year":"2024","unstructured":"Byrne BE, Siaw-Acheampong K, Evans O, Taylor J, Huddy F, Nilsson M, et al. REsolution of Symptoms afTer Oesophago-gastric cancer REsection delphi (RESTOREd)-standardizing the definition, investigation and management of gastrointestinal symptoms and conditions after surgery. Br J Surg. 2024;111(12):znae286. https:\/\/doi.org\/10.1093\/bjs\/znae286.","journal-title":"Br J Surg"},{"issue":"1","key":"1723_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10120-014-0344-4","volume":"18","author":"K Nakada","year":"2015","unstructured":"Nakada K, Ikeda M, Takahashi M, Kinami S, Yoshida M, Uenosono Y, et al. Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients. Gastric Cancer. 2015;18(1):147\u201358. https:\/\/doi.org\/10.1007\/s10120-014-0344-4.","journal-title":"Gastric Cancer"},{"issue":"7","key":"1723_CR24","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ijsu.2014.05.067","volume":"12","author":"SS Lee","year":"2014","unstructured":"Lee SS, Chung HY, Kwon OK, Yu W. Quality of life in cancer survivors 5 years or more after total gastrectomy: a case-control study. Int J Surg. 2014;12(7):700\u20135. https:\/\/doi.org\/10.1016\/j.ijsu.2014.05.067.","journal-title":"Int J Surg"},{"issue":"3","key":"1723_CR25","doi-asserted-by":"publisher","first-page":"763","DOI":"10.4143\/crt.2020.1270","volume":"53","author":"BW Eom","year":"2021","unstructured":"Eom BW, Lee J, Lee IS, Son YG, Ryu KW, Kim SG, et al. Development and validation of a symptom-focused quality of life questionnaire (KOQUSS-40) for gastric cancer patients after gastrectomy. Cancer Res Treat. 2021;53(3):763\u201372. https:\/\/doi.org\/10.4143\/crt.2020.1270.","journal-title":"Cancer Res Treat"},{"issue":"2","key":"1723_CR26","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5230\/jgc.2025.25.e26","volume":"25","author":"SE Oh","year":"2025","unstructured":"Oh SE, Suh YS, An JY, Ryu KW, Cho I, Kim SG, et al. Prospective multicenter observational study on postoperative quality of life according to type of gastrectomy for gastric cancer. J Gastric Cancer. 2025;25(2):382\u201399. https:\/\/doi.org\/10.5230\/jgc.2025.25.e26.","journal-title":"J Gastric Cancer"},{"issue":"11","key":"1723_CR27","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1097\/JS9.0000000000000620","volume":"109","author":"J Yu","year":"2023","unstructured":"Yu J, Wang Z, Yang H, Zhang C, Xing J, Cui M, et al. Long-term health-related quality of life in patients with gastric cancer after total or distal gastrectomy: a propensity score-matched cohort study. Int J Surg. 2023;109(11):3283\u201393. https:\/\/doi.org\/10.1097\/JS9.0000000000000620.","journal-title":"Int J Surg"},{"issue":"1","key":"1723_CR28","doi-asserted-by":"publisher","first-page":"8632","DOI":"10.1038\/s41598-025-90866-8","volume":"15","author":"H Chen","year":"2025","unstructured":"Chen H, Jing S, Li Z, Cao L, Guan W, Chen X, et al. Impact of distal or pylorus preserving gastrectomy on postoperative quality of life in T1 stage middle third gastric cancer patients. Sci Rep. 2025;15(1):8632. https:\/\/doi.org\/10.1038\/s41598-025-90866-8.","journal-title":"Sci Rep"},{"issue":"6","key":"1723_CR29","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/01635581.2024.2340782","volume":"76","author":"S Hanzawa","year":"2024","unstructured":"Hanzawa S, Kikuchi S, Kuroda S, Shoji R, Kashima H, Matsumi Y, et al. Perioperative and postoperative continuous nutritional counseling improves quality of life of gastric cancer patient undergoing gastrectomy. Nutr Cancer. 2024;76(6):476\u201385. https:\/\/doi.org\/10.1080\/01635581.2024.2340782.","journal-title":"Nutr Cancer"},{"issue":"3","key":"1723_CR30","doi-asserted-by":"publisher","first-page":"921","DOI":"10.21037\/apm.2020.04.14","volume":"9","author":"Q Gao","year":"2020","unstructured":"Gao Q, Li H, Zou Y, Hou B, Liu L. Effectiveness of a comprehensive post-operative health education program in improving quality of life after gastric cancer surgery. Ann Palliat Med. 2020;9(3):921\u20136. https:\/\/doi.org\/10.21037\/apm.2020.04.14.","journal-title":"Ann Palliat Med"},{"issue":"10","key":"1723_CR31","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1007\/s11606-021-06737-1","volume":"36","author":"A Sharma","year":"2021","unstructured":"Sharma A, Minh Duc NT, Luu Lam Thang T, Nam NH, Ng SJ, Abbas KS, et al. A consensus-based Checklist for Reporting Of Survey Studies (CROSS). J Gen Intern Med. 2021;36(10):3179\u201387. https:\/\/doi.org\/10.1007\/s11606-021-06737-1.","journal-title":"J Gen Intern Med"},{"issue":"26","key":"1723_CR32","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMp1802313","volume":"378","author":"AJH Kind","year":"2018","unstructured":"Kind AJH, Buckingham WR. Making neighborhood-disadvantage metrics accessible\u2014the Neighborhood Atlas. N Engl J Med. 2018;378(26):2456\u20138. https:\/\/doi.org\/10.1056\/NEJMp1802313.","journal-title":"N Engl J Med"},{"key":"1723_CR33","unstructured":"Center for Health Disparities Research. Neighborhood Atlas: 2023 Area Deprivation Index v3.0 [Internet]. Madison, WI: University of Wisconsin School of Medicine and Public Health [cited 2025 December 3]. Available from: https:\/\/www.neighborhoodatlas.medicine.wisc.edu\/."},{"issue":"2","key":"1723_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF01535722","volume":"33","author":"J Svedlund","year":"1988","unstructured":"Svedlund J, Sjodin I, Dotevall G. GSRS\u2014a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33(2):129\u201334. https:\/\/doi.org\/10.1007\/BF01535722.","journal-title":"Dig Dis Sci"},{"key":"1723_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1477-7525-6-12","volume":"6","author":"KR Kulich","year":"2008","unstructured":"Kulich KR, Madisch A, Pacini F, Piqu\u00e9 JM, Regula J, Van Rensburg CJ, et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual Life Outcomes. 2008;6:12. https:\/\/doi.org\/10.1186\/1477-7525-6-12.","journal-title":"Health Qual Life Outcomes"},{"issue":"40","key":"1723_CR36","doi-asserted-by":"publisher","first-page":"8978","DOI":"10.3748\/wjg.v22.i40.8978","volume":"22","author":"K Nakada","year":"2016","unstructured":"Nakada K, Takahashi M, Ikeda M, Kinami S, Yoshida M, Uenosono Y, et al. Factors affecting the quality of life of patients after gastrectomy as assessed using the newly developed PGSAS-45 scale: a nationwide multi-institutional study. World J Gastroenterol. 2016;22(40):8978\u201390. https:\/\/doi.org\/10.3748\/wjg.v22.i40.8978.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"1723_CR37","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1245\/s10434-021-11136-1","volume":"29","author":"C Kunisaki","year":"2022","unstructured":"Kunisaki C, Yoshida K, Yoshida M, Matsumoto S, Arigami T, Sugiyama Y, et al. Effects of proximal gastrectomy and various clinical factors on postoperative quality of life for upper-third gastric cancer assessed using the Postgastrectomy Syndrome Assessment Scale-45 (PGSAS-45): a PGSAS NEXT study. Ann Surg Oncol. 2022;29(6):3899\u2013908. https:\/\/doi.org\/10.1245\/s10434-021-11136-1.","journal-title":"Ann Surg Oncol"},{"issue":"18","key":"1723_CR38","doi-asserted-by":"publisher","first-page":"e71258","DOI":"10.1002\/cam4.71258","volume":"14","author":"Y Liu","year":"2025","unstructured":"Liu Y, Yan M, Lin Z, Wei S, Li Y, Lin Z, et al. Short- and mid-term outcomes of proximal gastrectomy with double-tract reconstruction versus total gastrectomy in early-stage proximal gastric cancer. Cancer Med. 2025;14(18):e71258. https:\/\/doi.org\/10.1002\/cam4.71258.","journal-title":"Cancer Med"},{"issue":"20","key":"1723_CR39","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1002\/cncr.28814","volume":"120","author":"JA de Souza","year":"2014","unstructured":"de Souza JA, Yap BJ, Hlubocky FJ, Wroblewski K, Ratain MJ, Cella D, et al. The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer. 2014;120(20):3245\u201353. https:\/\/doi.org\/10.1002\/cncr.28814.","journal-title":"Cancer"},{"issue":"7","key":"1723_CR40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00520-024-08601-4","volume":"32","author":"LB Thomy","year":"2024","unstructured":"Thomy LB, Crichton M, Jones L, Yates PM, Hart NH, Collins LG, et al. Measures of financial toxicity in cancer survivors: a systematic review. Support Care Cancer. 2024;32(7):403. https:\/\/doi.org\/10.1007\/s00520-024-08601-4.","journal-title":"Support Care Cancer"},{"issue":"4","key":"1723_CR41","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/0272989X03256005","volume":"23","author":"JC Brehaut","year":"2003","unstructured":"Brehaut JC, O\u2019Connor AM, Wood TJ, Hack TF, Siminoff L, Gordon E, et al. Validation of a decision regret scale. Med Decis Mak. 2003;23(4):281\u201392. https:\/\/doi.org\/10.1177\/0272989X03256005.","journal-title":"Med Decis Mak"},{"issue":"6","key":"1723_CR42","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1177\/0272989X16636113","volume":"36","author":"MM Becerra P\u00e9rez","year":"2016","unstructured":"Becerra P\u00e9rez MM, Menear M, Brehaut JC, L\u00e9gar\u00e9 F. Extent and predictors of decision regret about health care decisions: a systematic review. Med Decis Mak. 2016;36(6):777\u201390. https:\/\/doi.org\/10.1177\/0272989X16636113.","journal-title":"Med Decis Mak"},{"key":"1723_CR43","unstructured":"The Ottawa Hospital Research Institute. User Manual\u2014Decision Regret Scale [Internet]. Ottawa, Ontario: University of Ottawa. 2003 [cited 2026 January 15]. Available from: https:\/\/decisionaid.ohri.ca\/docs\/develop\/User_Manuals\/UM_Regret_Scale.pdf."},{"key":"1723_CR44","unstructured":"FACIT Group. COmprehensive Score for financial Toxicity (COST) Scoring Guidelines (Version 2) [Internet]. 2017 September [cited 2026 January 15]. Available from: https:\/\/www.facit.org\/measures-scoring-downloads\/cost-scoring-downloads."},{"issue":"11","key":"1723_CR45","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/s0895-4356(98)00096-1","volume":"51","author":"S Fukuhara","year":"1998","unstructured":"Fukuhara S, Ware JE Jr, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol. 1998;51(11):1045\u201353. https:\/\/doi.org\/10.1016\/s0895-4356(98)00096-1.","journal-title":"J Clin Epidemiol"},{"key":"1723_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.urology.2023.04.040","volume":"179","author":"V Glazyrine","year":"2023","unstructured":"Glazyrine V, Au D, Starkey J, Thompson J, Parker W. Evaluating financial toxicity in urologic practice. Urology. 2023;179:16\u201322. https:\/\/doi.org\/10.1016\/j.urology.2023.04.040.","journal-title":"Urology"},{"issue":"2","key":"1723_CR47","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/jso.27871","volume":"131","author":"H Muaddi","year":"2025","unstructured":"Muaddi H, Zironda A, Zhang C, Day C, Starlinger PP, Warner SG, et al. Financial toxicity of long-term survivors who underwent pancreatoduodenectomy for pancreatic ductal adenocarcinoma. J Surg Oncol. 2025;131(2):232\u201341. https:\/\/doi.org\/10.1002\/jso.27871.","journal-title":"J Surg Oncol"},{"issue":"5","key":"1723_CR48","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/SLA.0000000000006053","volume":"279","author":"C Zhang","year":"2024","unstructured":"Zhang C, Zironda A, Vierkant RA, Starlinger P, Warner S, Smoot R, et al. Quality of life and gastrointestinal symptoms in long-term survivors of pancreatic cancer following pancreatoduodenectomy. Ann Surg. 2024;279(5):842\u20139. https:\/\/doi.org\/10.1097\/SLA.0000000000006053.","journal-title":"Ann Surg"},{"issue":"11","key":"1723_CR49","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1200\/OP.2023.19.11_suppl.23","volume":"19","author":"P Karukonda","year":"2023","unstructured":"Karukonda P, Chino F, Wan Z, Niedzwiecki D, Brizel DM, Mowery YM. Patient-reported outcomes and financial toxicity in head and neck cancer (PaRTNer): longitudinal assessment of financial toxicity and coping mechanisms. JCO Oncol Pract. 2023;19(11):S23. https:\/\/doi.org\/10.1200\/OP.2023.19.11_suppl.23.","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"1723_CR50","doi-asserted-by":"publisher","first-page":"e2350844","DOI":"10.1001\/jamanetworkopen.2023.50844","volume":"7","author":"S Kircher","year":"2024","unstructured":"Kircher S, Duan F, An N, Gareen IF, Sicks JD, Sadigh G, et al. Patient-reported financial burden of treatment for colon or rectal cancer. JAMA Netw Open. 2024;7(1):e2350844. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.50844.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1723_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/pon.5763","volume":"31","author":"C Benedict","year":"2022","unstructured":"Benedict C, Fisher S, Schapira L, Chao S, Sackeyfio S, Sullivan T, et al. Greater financial toxicity relates to greater distress and worse quality of life among breast and gynecologic cancer survivors. Psychooncology. 2022;31(1):9\u201320. https:\/\/doi.org\/10.1002\/pon.5763.","journal-title":"Psychooncology"},{"issue":"4","key":"1723_CR52","doi-asserted-by":"publisher","first-page":"e246872","DOI":"10.1001\/jamanetworkopen.2024.6872","volume":"7","author":"ML Hsu","year":"2024","unstructured":"Hsu ML, Boulanger MC, Olson S, Eaton C, Prichett L, Guo M, et al. Unmet needs, quality of life, and financial toxicity among survivors of lung cancer. JAMA Netw Open. 2024;7(4):e246872. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.6872.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1723_CR53","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.annonc.2019.10.006","volume":"31","author":"SZ Hazell","year":"2020","unstructured":"Hazell SZ, Fu W, Hu C, Voong KR, Lee B, Peterson V, et al. Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life. Ann Oncol. 2020;31(1):96\u2013102. https:\/\/doi.org\/10.1016\/j.annonc.2019.10.006.","journal-title":"Ann Oncol"},{"issue":"7","key":"1723_CR54","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1245\/s10434-024-15236-6","volume":"31","author":"Y Hirata","year":"2024","unstructured":"Hirata Y, To C, Lyu H, Smith GL, Samuel JP, Tran Cao HS, et al. Prevalence of and factors associated with financial toxicity after pancreatectomy and gastrectomy. Ann Surg Oncol. 2024;31(7):4361\u201370. https:\/\/doi.org\/10.1245\/s10434-024-15236-6.","journal-title":"Ann Surg Oncol"},{"issue":"23","key":"1723_CR55","doi-asserted-by":"publisher","first-page":"8765","DOI":"10.1002\/cam4.3484","volume":"9","author":"AG Bauer","year":"2020","unstructured":"Bauer AG, Jefferson M, Nahhas GJ, Savage S, Drake R, Lilly M, et al. Financial toxicity and strain among men receiving prostate cancer care in an equal access healthcare system. Cancer Med. 2020;9(23):8765\u201371. https:\/\/doi.org\/10.1002\/cam4.3484.","journal-title":"Cancer Med"},{"issue":"4","key":"1723_CR56","first-page":"10762","volume":"28","author":"DA Ezeife","year":"2021","unstructured":"Ezeife DA, Morganstein BJ, Yip S, Ryan M, Law JH, Guan AY, et al. The financial impact of cancer care on renal cancer patients. Can J Urol. 2021;28(4):10762\u20137.","journal-title":"Can J Urol"},{"issue":"12","key":"1723_CR57","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1007\/s11605-016-3287-8","volume":"20","author":"J Muir","year":"2016","unstructured":"Muir J, Aronson M, Esplen MJ, Pollett A, Swallow CJ. Prophylactic total gastrectomy: a prospective cohort study of long-term impact on quality of life. J Gastrointest Surg. 2016;20(12):1950\u20138. https:\/\/doi.org\/10.1007\/s11605-016-3287-8.","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"1723_CR58","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/jmg-2022-108733","volume":"60","author":"LA Gamble","year":"2023","unstructured":"Gamble LA, Grant RRC, Samaranayake SG, Fasaye GA, Koh C, Korman L, et al. Decision-making and regret in patients with germline CDH1 variants undergoing prophylactic total gastrectomy. J Med Genet. 2023;60(3):241\u20136. https:\/\/doi.org\/10.1136\/jmg-2022-108733.","journal-title":"J Med Genet"},{"issue":"12","key":"1723_CR59","doi-asserted-by":"publisher","first-page":"7978","DOI":"10.1245\/s10434-024-16013-1","volume":"31","author":"A Graves","year":"2024","unstructured":"Graves A, Sadjadi J, Kosich M, Ward E, Sood D, Fahy B, et al. Decision regret in patients with appendiceal cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2024;31(12):7978\u201386. https:\/\/doi.org\/10.1245\/s10434-024-16013-1.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1723_CR60","doi-asserted-by":"publisher","first-page":"101870","DOI":"10.1016\/j.gassur.2024.10.025","volume":"29","author":"N Galouzis","year":"2025","unstructured":"Galouzis N, Khawam M, Alexander EV, Yallourakis MD, Mesropyan L, Luu C, et al. Decision regret and satisfaction with shared decision-making in pancreatic surgery. J Gastrointest Surg. 2025;29(1):101870. https:\/\/doi.org\/10.1016\/j.gassur.2024.10.025.","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"1723_CR61","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/jso.70066","volume":"132","author":"JE Fitzgerald","year":"2025","unstructured":"Fitzgerald JE, Austin P, Monton O, Bechthold AC, Kopecky KE. Patient regret after gastrointestinal surgery for cancer: a narrative review. J Surg Oncol. 2025;132(6):1003\u201310. https:\/\/doi.org\/10.1002\/jso.70066.","journal-title":"J Surg Oncol"},{"issue":"12","key":"1723_CR62","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.1177\/00031348231184197","volume":"89","author":"H Kinoshita","year":"2023","unstructured":"Kinoshita H, Nishigori T, Nakabe T, Shimoike N, Sato K, Imanaka Y, et al. Factors associated with postoperative decisional regret in patients undergoing gastrointestinal cancer surgery: a prospective cohort study. Am Surg. 2023;89(12):6070\u20137. https:\/\/doi.org\/10.1177\/00031348231184197.","journal-title":"Am Surg"},{"issue":"11","key":"1723_CR63","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.3748\/wjg.v23.i11.2068","volume":"23","author":"M Takahashi","year":"2017","unstructured":"Takahashi M, Terashima M, Kawahira H, Nagai E, Uenosono Y, Kinami S, et al. Quality of life after total vs distal gastrectomy with Roux-en-Y reconstruction: use of the Postgastrectomy Syndrome Assessment Scale-45. World J Gastroenterol. 2017;23(11):2068\u201376. https:\/\/doi.org\/10.3748\/wjg.v23.i11.2068.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1723_CR64","doi-asserted-by":"publisher","first-page":"461","DOI":"10.4240\/wjgs.v13.i5.461","volume":"13","author":"K Nakada","year":"2021","unstructured":"Nakada K, Kawashima Y, Kinami S, Fukushima R, Yabusaki H, Seshimo A, et al. Comparison of effects of six main gastrectomy procedures on patients\u2019 quality of life assessed by Postgastrectomy Syndrome Assessment Scale-45. World J Gastrointest Surg. 2021;13(5):461\u201375. https:\/\/doi.org\/10.4240\/wjgs.v13.i5.461.","journal-title":"World J Gastrointest Surg"},{"issue":"11","key":"1723_CR65","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1038\/ajg.2009.456","volume":"104","author":"R Gertler","year":"2009","unstructured":"Gertler R, Rosenberg R, Feith M, Schuster T, Friess H. Pouch vs. no pouch following total gastrectomy: meta-analysis and systematic review. Am J Gastroenterol. 2009;104(11):2838\u201351. https:\/\/doi.org\/10.1038\/ajg.2009.456.","journal-title":"Am J Gastroenterol"},{"key":"1723_CR66","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/OTT.S99628","volume":"10","author":"P Zon\u010da","year":"2016","unstructured":"Zon\u010da P, Mal\u00fd T, Ihn\u00e1t P, Peteja M, Kraft O, Kuca K. J-pouch versus Roux-en-Y reconstruction after gastrectomy: functional assessment and quality of life (randomized trial). Onco Targets Ther. 2016;10:13\u20139. https:\/\/doi.org\/10.2147\/OTT.S99628.","journal-title":"Onco Targets Ther"},{"issue":"6","key":"1723_CR67","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1097\/SLA.0000000000003082","volume":"269","author":"NL Syn","year":"2019","unstructured":"Syn NL, Wee I, Shabbir A, Kim G, So JB. Pouch versus no pouch following total gastrectomy: meta-analysis of randomized and non-randomized studies. Ann Surg. 2019;269(6):1041\u201353. https:\/\/doi.org\/10.1097\/SLA.0000000000003082.","journal-title":"Ann Surg"},{"issue":"3","key":"1723_CR68","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.gassur.2023.12.015","volume":"28","author":"M Realis Luc","year":"2024","unstructured":"Realis Luc M, Bonomi AM, Carbone F, Ascari F, de Pascale S, Fumagalli Romario U. Roux-en-Y with or without jejunal J-pouch reconstruction after total gastrectomy for gastric cancer: systematic review and meta-analysis of long-term functional outcomes. J Gastrointest Surg. 2024;28(3):291\u2013300. https:\/\/doi.org\/10.1016\/j.gassur.2023.12.015.","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"1723_CR69","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s10120-015-0529-5","volume":"19","author":"Y Ito","year":"2016","unstructured":"Ito Y, Yoshikawa T, Fujiwara M, Kojima H, Matsui T, Mochizuki Y, et al. Quality of life and nutritional consequences after aboral pouch reconstruction following total gastrectomy for gastric cancer: randomized controlled trial CCG1101. Gastric Cancer. 2016;19(3):977\u201385. https:\/\/doi.org\/10.1007\/s10120-015-0529-5.","journal-title":"Gastric Cancer"},{"issue":"3","key":"1723_CR70","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10120-018-0893-z","volume":"22","author":"C Tanaka","year":"2019","unstructured":"Tanaka C, Kanda M, Murotani K, Yoshikawa T, Cho H, Ito Y, et al. Long-term quality of life and nutrition status of the aboral pouch reconstruction after total gastrectomy for gastric cancer: a prospective multicenter observational study (CCOG1505). Gastric Cancer. 2019;22(3):607\u201316. https:\/\/doi.org\/10.1007\/s10120-018-0893-z.","journal-title":"Gastric Cancer"},{"key":"1723_CR71","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.20034","author":"AK Patel","year":"2026","unstructured":"Patel AK, Sethi NS, Park H. Gastric cancer: a review. JAMA. 2026. https:\/\/doi.org\/10.1001\/jama.2025.20034","journal-title":"JAMA"},{"issue":"3","key":"1723_CR72","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF03404376","volume":"101","author":"LL Sykes","year":"2010","unstructured":"Sykes LL, Walker RL, Ngwakongnwi E, Quan H. A systematic literature review on response rates across racial and ethnic populations. Can J Public Health. 2010;101(3):213\u20139. https:\/\/doi.org\/10.1007\/BF03404376.","journal-title":"Can J Public Health"},{"issue":"11","key":"1723_CR73","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1007\/s00520-014-2250-z","volume":"22","author":"R Pullmer","year":"2014","unstructured":"Pullmer R, Linden W, Rnic K, Vodermaier A. Measuring symptoms in gastrointestinal cancer: a systematic review of assessment instruments. Support Care Cancer. 2014;22(11):2941\u201355. https:\/\/doi.org\/10.1007\/s00520-014-2250-z.","journal-title":"Support Care Cancer"},{"issue":"1","key":"1723_CR74","doi-asserted-by":"publisher","first-page":"247","DOI":"10.5230\/jgc.2025.25.e7","volume":"25","author":"J Kim","year":"2025","unstructured":"Kim J, Lee HJ. Function preserving gastrectomy and quality of life. J Gastric Cancer. 2025;25(1):247\u201360. https:\/\/doi.org\/10.5230\/jgc.2025.25.e7.","journal-title":"J Gastric Cancer"},{"issue":"8","key":"1723_CR75","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/s0959-8049(00)00417-2","volume":"37","author":"CW Vickery","year":"2001","unstructured":"Vickery CW, Blazeby JM, Conroy T, Arraras J, Sezer O, Koller M, et al. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. Eur J Cancer. 2001;37(8):966\u201371. https:\/\/doi.org\/10.1016\/s0959-8049(00)00417-2.","journal-title":"Eur J Cancer"},{"issue":"6","key":"1723_CR76","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/cncr.25556","volume":"117","author":"SN Garland","year":"2011","unstructured":"Garland SN, Pelletier G, Lawe A, Biagioni BJ, Easaw J, Eliasziw M, et al. Prospective evaluation of the reliability, validity, and minimally important difference of the functional assessment of cancer therapy-gastric (FACT-Ga) quality-of-life instrument. Cancer. 2011;117(6):1302\u201312. https:\/\/doi.org\/10.1002\/cncr.25556.","journal-title":"Cancer"},{"issue":"3","key":"1723_CR77","doi-asserted-by":"publisher","first-page":"763","DOI":"10.4143\/crt.2020.1270","volume":"53","author":"BW Eom","year":"2021","unstructured":"Eom BW, Lee J, Lee IS, Son YG, Ryu KW, Kim SG, et al. Development and validation of a symptom-focused quality of life questionnaire (KOQUSS-40) for gastric cancer patients after gastrectomy. Cancer Res Treat. 2021;53(3):763\u201372. https:\/\/doi.org\/10.4143\/crt.2020.1270.","journal-title":"Cancer Res Treat"},{"key":"1723_CR78","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2024.1104","author":"BW Eom","year":"2025","unstructured":"Eom BW, Ryu KW, An JY, Suh YS, Cho I, Kim SG, et al. Detection ability of quality of life changes and responsiveness of the KOQUSS-40 and the EORTC QLQ-C30\/STO22 in patients who underwent gastrectomy: a prospective comparative study. Cancer Res Treat. 2025. . https:\/\/doi.org\/10.4143\/crt.2024.1104","journal-title":"Cancer Res Treat"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-026-01723-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-026-01723-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-026-01723-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:12:37Z","timestamp":1777385557000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-026-01723-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1723"],"URL":"https:\/\/doi.org\/10.1007\/s10120-026-01723-0","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no relevant conflict of interest or disclosures related to this work. Frank Lee has received unrelated grant funding from Johnson & Johnson. Steven Bowers has received unrelated consultation fees for BK Medical and is the inventor\/founder of Suture Shield Inc. Cornelius Thiels declares unrelated grant funding from the Dalio Foundation, consultation fees from Boston Scientific, and an unrelated relationship with apoQlar. Travis Grotz received honorarium for scientific advisory board roles for Sentinal Biotherapeutics and Ferranova and a consultation fee from Agenus.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent to be included in the study, or the equivalent, was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent to be included in the study, or the equivalent, was obtained from all patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}}]}}